Debiopharm International SA

Quick facts

Marketed products

• Placebo Tablet or Capsule
  A placebo tablet or capsule contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.
• Vancomycin IV · Infectious Disease
  Vancomycin inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors, preventing cross-linking and causing cell wall disruption.

Phase 3 pipeline

• Debio 4126 · Oncology
  Debio 4126 is a selective inhibitor of mitochondrial complex I that disrupts energy metabolism in cancer cells.
• Debio 4326 · Oncology
  Debio 4326 is a selective inhibitor of mitochondrial complex I that disrupts energy metabolism in cancer cells.
• triptorelin embonate (INN)

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Debiopharm International SA portfolio CI brief
• Debiopharm International SA pipeline updates RSS